"Baseline Characteristics and Utilization of Medical Therapies in Acute Hospitalized and Chronic Heart Failure Patients Enrolled in GRASP-HF: Differences Between ICARe-HF and Non-ICARe-HF Centres".

IF 10.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Ovidiu Chioncel, Gianluigi Savarese, Cecile Laroche, Offer Amir, Mariya Tokmakova, Mathilde Boutard, Antonio Cannata, Hamlet Hayrapetyan, Hans-Eckart Sarnighausen, Noha El Ouafi, Emilie Soriano, Brenda Moura, Lars Lund, Marianna Adamo, Wendy Guillouche, Maurizio Volterani, Bernard Iung, Wilfried Mullens, Marco Metra
{"title":"\"Baseline Characteristics and Utilization of Medical Therapies in Acute Hospitalized and Chronic Heart Failure Patients Enrolled in GRASP-HF: Differences Between ICARe-HF and Non-ICARe-HF Centres\".","authors":"Ovidiu Chioncel, Gianluigi Savarese, Cecile Laroche, Offer Amir, Mariya Tokmakova, Mathilde Boutard, Antonio Cannata, Hamlet Hayrapetyan, Hans-Eckart Sarnighausen, Noha El Ouafi, Emilie Soriano, Brenda Moura, Lars Lund, Marianna Adamo, Wendy Guillouche, Maurizio Volterani, Bernard Iung, Wilfried Mullens, Marco Metra","doi":"10.1093/ejhf/xuag317","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Global Registries and Surveys Programme-Heart Failure (GRASP-HF) is a prospective, multicentre, international observational study assessing implementation of the 2021/2023 ESC-HF-Guidelines. GRASP-HF is aligned with the Improving Care through Accreditation and Recognition in Heart Failure (ICARe-HF) programme, which links centre-characteristics with guideline-implementation performance.</p><p><strong>Aims: </strong>To compare baseline characteristics, guideline-directed-medical-therapy (GDMT) implementation, and in-hospital outcomes between GRASP-HF patients managed in centres participating or not participating in the ICARe-HF programme.</p><p><strong>Methods: </strong>GRASP-HF patients were stratified by ICARe-HF participation, clinical settings, acute (AHF) vs chronic HF (CHF) and ejection fraction (EF) subtypes. Hierarchical multivariable logistic regression models evaluated associations with quadruple therapy implementation and in-hospital mortality.</p><p><strong>Results: </strong>Among 10,936 patients (63.3% CHF, 36.7% AHF), patients from ICARe-HF participating centres (51.3%) were older, more comorbid but with less severe congestion. In both CHF and AHF, ICARe-HF centres demonstrated greater GDMT utilization, particularly angiotensin receptor-neprilysin inhibitors and sodium-glucose-cotransporter-2 inhibitors. In HFrEF, quadruple therapy was more frequently implemented (47% vs 40% in CHF; 27% vs 24% at AHF discharge) and remained associated with ICARe-HF participation after adjustment, Odd Ratio (OR) =1.73, 95% Confidence Interval (CI) :1.17-2.55. Target doses remained suboptimal, particularly after AHF. Although crude in-hospital mortality was lower in ICARe-HF centres (2.3% vs 5.5%), this association was attenuated after multivariable adjustment (OR=0.87, 95% CI:0.48-1.56).</p><p><strong>Conclusions: </strong>Participation in the ICARe-HF programme was associated with more comprehensive implementation of contemporary GDMT, particularly in HFrEF. The association with in-hospital mortality was attenuated after adjustment and should be considered exploratory.</p>","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":" ","pages":""},"PeriodicalIF":10.3000,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejhf/xuag317","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The Global Registries and Surveys Programme-Heart Failure (GRASP-HF) is a prospective, multicentre, international observational study assessing implementation of the 2021/2023 ESC-HF-Guidelines. GRASP-HF is aligned with the Improving Care through Accreditation and Recognition in Heart Failure (ICARe-HF) programme, which links centre-characteristics with guideline-implementation performance.

Aims: To compare baseline characteristics, guideline-directed-medical-therapy (GDMT) implementation, and in-hospital outcomes between GRASP-HF patients managed in centres participating or not participating in the ICARe-HF programme.

Methods: GRASP-HF patients were stratified by ICARe-HF participation, clinical settings, acute (AHF) vs chronic HF (CHF) and ejection fraction (EF) subtypes. Hierarchical multivariable logistic regression models evaluated associations with quadruple therapy implementation and in-hospital mortality.

Results: Among 10,936 patients (63.3% CHF, 36.7% AHF), patients from ICARe-HF participating centres (51.3%) were older, more comorbid but with less severe congestion. In both CHF and AHF, ICARe-HF centres demonstrated greater GDMT utilization, particularly angiotensin receptor-neprilysin inhibitors and sodium-glucose-cotransporter-2 inhibitors. In HFrEF, quadruple therapy was more frequently implemented (47% vs 40% in CHF; 27% vs 24% at AHF discharge) and remained associated with ICARe-HF participation after adjustment, Odd Ratio (OR) =1.73, 95% Confidence Interval (CI) :1.17-2.55. Target doses remained suboptimal, particularly after AHF. Although crude in-hospital mortality was lower in ICARe-HF centres (2.3% vs 5.5%), this association was attenuated after multivariable adjustment (OR=0.87, 95% CI:0.48-1.56).

Conclusions: Participation in the ICARe-HF programme was associated with more comprehensive implementation of contemporary GDMT, particularly in HFrEF. The association with in-hospital mortality was attenuated after adjustment and should be considered exploratory.

“急性住院和慢性心力衰竭患者入组GRASP-HF的基线特征和药物治疗的使用:ICARe-HF和非ICARe-HF中心的差异”。
背景:全球心力衰竭登记和调查项目(grip - hf)是一项评估2021/2023年esc - hf指南实施情况的前瞻性、多中心、国际观察性研究。grip - hf与通过心力衰竭认证和识别改善护理(ICARe-HF)计划保持一致,该计划将中心特征与指南实施绩效联系起来。目的:比较在参与或不参与ICARe-HF计划的中心管理的GRASP-HF患者的基线特征、指南导向的药物治疗(GDMT)实施和住院结果。方法:根据ICARe-HF参与情况、临床情况、急性(AHF) vs慢性HF (CHF)和射血分数(EF)亚型对grip -HF患者进行分层。分层多变量logistic回归模型评估了四联疗法实施和住院死亡率之间的关系。结果:在10936例患者(63.3% CHF, 36.7% AHF)中,来自ICARe-HF参与中心的患者(51.3%)年龄较大,合合症较多,但充血程度较轻。在CHF和AHF中,ICARe-HF中心显示出更高的GDMT利用率,特别是血管紧张素受体-neprilysin抑制剂和钠-葡萄糖-cotransporter-2抑制剂。在HFrEF中,四联治疗的实施频率更高(47% vs 40% CHF; 27% vs 24% AHF出院),调整后仍与ICARe-HF参与相关,奇比(OR) =1.73, 95%可信区间(CI):1.17-2.55。目标剂量仍然不够理想,特别是在AHF之后。尽管ICARe-HF中心的院内粗死亡率较低(2.3% vs 5.5%),但在多变量调整后,这种关联减弱(OR=0.87, 95% CI:0.48-1.56)。结论:参与ICARe-HF计划与更全面地实施当代GDMT相关,特别是在HFrEF中。调整后与住院死亡率的相关性减弱,应考虑探索性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Heart Failure
European Journal of Heart Failure 医学-心血管系统
CiteScore
27.30
自引率
11.50%
发文量
365
审稿时长
1 months
期刊介绍: European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书